Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Novavax Inc.

    NASDAQ: NVAX · Real-Time Price · USD
    7.04
    0.10 (1.44%)
    At close: Jun 16, 2025, 3:59 PM
    6.94
    -1.35%
    Pre-market: Jun 17, 2025, 05:10 AM EDT

    Novavax Statistics

    Share Statistics

    Novavax has 161.97M shares outstanding. The number of shares has increased by 14.56% in one year.

    Shares Outstanding

    n/a
    		 161.97M

    Shares Change (YoY)

    n/a
    		 14.56%

    Shares Change (QoQ)

    n/a
    		 0.41%

    Owned by Institutions (%)

    n/a
    		 64.13%

    Shares Floating

    n/a
    		 147.6M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,000

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 44.7M, so 27.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 44.7M

    Short % of Shares Out

    n/a
    		 27.6%

    Short % of Float

    n/a
    		 27.7%

    Short Ratio (days to cover)

    n/a
    		 2.65

    Valuation Ratios

    The PE ratio is -6.53 and the forward PE ratio is 19.25. Novavax's PEG ratio is 0.08.

    PE Ratio

    n/a
    		 -6.53

    Forward PE

    n/a
    		 19.25

    PS Ratio

    n/a
    		 1.79

    Forward PS

    n/a
    		 2.9

    PB Ratio

    n/a
    		 -1.96

    P/FCF Ratio

    n/a
    		 -12.2

    PEG Ratio

    n/a
    		 0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Novavax.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.98, with a Debt / Equity ratio of -0.37.

    Current Ratio

    n/a
    		 0.98

    Quick Ratio

    n/a
    		 0.97

    Debt / Equity

    n/a
    		 -0.37

    Debt / EBITDA

    n/a
    		 -2.13

    Debt / FCF

    n/a
    		 -2.3

    Interest Coverage

    n/a
    		 -12.4

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $716,556.72

    Profits Per Employee

    n/a
    		 $-196,952.73

    Employee Count

    n/a
    		 952

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 23.17

    Taxes

    Income Tax

    n/a
    		 10.88M

    Effective Tax Rate

    n/a
    		 -6.16%

    Stock Price Statistics

    The stock price has increased by -49.89% in the last 52 weeks. The beta is 2.77, so Novavax's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.77

    52-Week Price Change

    n/a
    		 -49.89%

    50-Day Moving Average

    n/a
    		 6.71

    200-Day Moving Average

    n/a
    		 8.76

    Relative Strength Index (RSI)

    n/a
    		 50.14

    Average Volume (20 Days)

    n/a
    		 8,590,265

    Income Statement

    In the last 12 months, Novavax had revenue of 682.16M and earned -187.5M in profits. Earnings per share was -1.23.

    Revenue

    n/a
    		 682.16M

    Gross Profit

    n/a
    		 479.42M

    Operating Income

    n/a
    		 -248.93M

    Net Income

    n/a
    		 -187.5M

    EBITDA

    n/a
    		 -108.04M

    EBIT

    n/a
    		 -156.54M

    Earnings Per Share (EPS)

    n/a
    		 -1.23
    Full Income Statement

    Balance Sheet

    The company has 530.23M in cash and 230.42M in debt, giving a net cash position of 299.81M.

    Cash & Cash Equivalents

    n/a
    		 530.23M

    Total Debt

    n/a
    		 230.42M

    Net Cash

    n/a
    		 299.81M

    Retained Earnings

    n/a
    		 -5.01B

    Total Assets

    n/a
    		 1.29B

    Working Capital

    n/a
    		 445.86M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -87.26M and capital expenditures -13.06M, giving a free cash flow of -100.32M.

    Operating Cash Flow

    n/a
    		 -87.26M

    Capital Expenditures

    n/a
    		 -13.06M

    Free Cash Flow

    n/a
    		 -100.32M

    FCF Per Share

    n/a
    		 -0.66
    Full Cash Flow Statement

    Margins

    Gross margin is 70.28%, with operating and profit margins of -36.49% and -27.49%.

    Gross Margin

    n/a
    		 70.28%

    Operating Margin

    n/a
    		 -36.49%

    Pretax Margin

    n/a
    		 -25.89%

    Profit Margin

    n/a
    		 -27.49%

    EBITDA Margin

    n/a
    		 -15.84%

    EBIT Margin

    n/a
    		 -36.49%

    FCF Margin

    n/a
    		 -14.71%

    Dividends & Yields

    NVAX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NVAX is $22, which is 212.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 212.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 May 10, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -1.68

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist